FDA Inspection
Stanley Specialty Pharmacy Compounding and Wellness CenterStanley Specialty Pharmacy Compounding and Wellness Center – FDA Inspection, Oct 1, 2021
Record Details
This FDA Inspection record concerns Stanley Specialty Pharmacy Compounding and Wellness Center, with an inspection on October 1, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- October 1, 2021
- Product Type
- Drugs
View Company Profile
ID · 31f1b76d-b181-4ddf-be85-e5062f971866
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1153610
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.113(b)Validation lacking for sterile drug products
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Stanley Specialty Pharmacy Compounding and Wellness Center
2| Date | Classification | Office | Project area |
|---|---|---|---|
| August 4, 2017 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 7, 2016 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
Other documents for Stanley Specialty Pharmacy Compounding and Wellness Center
- FDA Inspection 1022804 - 2017-08-04
- FDA Inspection 987173 - 2016-07-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.